Skip to main content
Top
Published in: International Ophthalmology 9/2020

01-09-2020 | Subarachnoid Hemorrhage | Original Paper

Clinical observations and considerations in the treatment of Terson syndrome using 23G vitrectomy

Authors: Chengqun Ju, Shanshan Li, Chao Huang, Ying Li, Hong kyungwan, Fang Zhou, Jianqiao Li

Published in: International Ophthalmology | Issue 9/2020

Login to get access

Abstract

Purpose

This retrospective study analyzed the results of 23G vitrectomy for the treatment of intraocular hemorrhage in patients with Terson syndrome. The pathogenesis of Terson syndrome and the timing of vitrectomy are discussed.

Methods

Eight eyes of eight patients were included in the study. Intrasurgical images were acquired, and membranes peeled off during surgery were subjected to pathological staining. Postoperative examination included visual acuity, intraocular pressure, funduscopy, and optical coherence tomography angiography.

Results

The course of visual impairment in the patients ranged from < 1 to 5 months; visual acuity ranged from light perception to 20/1000. Surgeries in the eight patients were all successful, and no severe complications were observed. Visual acuity improved in each operative eye. Pathological staining revealed only fibrous connective tissue, and no nerve fibers in the membranes peeled off during surgery. Optical coherence tomography angiography revealed no changes in blood vessel density in the inner layer of the retina of the operative eye compared with the non-operative eye in each patient.

Conclusions

Timely surgical intervention is necessary for the treatment of intraocular hemorrhage in patients with Terson syndrome. Clinical findings support the theory that intraocular blood results from stasis or rupture of retinal superficial peripapillary vessels caused by elevated intracranial pressure.
Literature
1.
go back to reference Litten M (1881) Ueber Einige von Allgemein-Klinischen Standpunkt aus Interessante Augenveränderungen. Berl Klin Wochenschr 18:23–37 Litten M (1881) Ueber Einige von Allgemein-Klinischen Standpunkt aus Interessante Augenveränderungen. Berl Klin Wochenschr 18:23–37
2.
go back to reference De Terson A (1990) L´hemorrhagie dans le corps vitre au cours de l´hemorrhagie cerebrale. Clin Ophthalmo 6:309–312 De Terson A (1990) L´hemorrhagie dans le corps vitre au cours de l´hemorrhagie cerebrale. Clin Ophthalmo 6:309–312
3.
go back to reference Kuhn F, Morris R, Witherspoon CD, Mester V (1998) Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology 105:472–477PubMedCrossRef Kuhn F, Morris R, Witherspoon CD, Mester V (1998) Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology 105:472–477PubMedCrossRef
4.
go back to reference Pfausler B, Belcl R, Metzler R, Mohsenipour I, Schmutzhard E (1996) Terson’s syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg 85:392–394PubMedCrossRef Pfausler B, Belcl R, Metzler R, Mohsenipour I, Schmutzhard E (1996) Terson’s syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg 85:392–394PubMedCrossRef
5.
go back to reference Ogawa T, Kitaoka T, Dake Y, Amemiya T (2001) Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology 108:1654–1656PubMedCrossRef Ogawa T, Kitaoka T, Dake Y, Amemiya T (2001) Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology 108:1654–1656PubMedCrossRef
6.
go back to reference Czorlich P, Skevas C, Knospe V, Vettorazzi E, Richard G, Wagenfeld L et al (2015) Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury. Neurosurg Rev 38:129–1236PubMedCrossRef Czorlich P, Skevas C, Knospe V, Vettorazzi E, Richard G, Wagenfeld L et al (2015) Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury. Neurosurg Rev 38:129–1236PubMedCrossRef
7.
go back to reference Nacef L, Zghal-Mokni I, Allagui I, Haba B, Daghfous F, Gaigi S et al (2004) Indications and results of vitrectomy in Terson syndrome. Tunis Med 82:461–464PubMed Nacef L, Zghal-Mokni I, Allagui I, Haba B, Daghfous F, Gaigi S et al (2004) Indications and results of vitrectomy in Terson syndrome. Tunis Med 82:461–464PubMed
8.
go back to reference Garweg JG, Koerner F (2009) Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol 87:222–226PubMedCrossRef Garweg JG, Koerner F (2009) Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol 87:222–226PubMedCrossRef
10.
go back to reference Castren JA (1963) Pathogenesis and treatment of Terson syndrome. Acta Ophthalmol 41:430–434CrossRef Castren JA (1963) Pathogenesis and treatment of Terson syndrome. Acta Ophthalmol 41:430–434CrossRef
12.
go back to reference Vanderlinden RG, Chisholm LD (1974) Vitreous hemorrhages and sudden increased intracranial pressure. J Neurosurg 41:167–176PubMedCrossRef Vanderlinden RG, Chisholm LD (1974) Vitreous hemorrhages and sudden increased intracranial pressure. J Neurosurg 41:167–176PubMedCrossRef
13.
go back to reference Dörner L, Affke K, Barth H, Mehdorn HM (2009) A subarachnoid haemorrhage primarily presenting as Terson’s syndrome. Cent Eur Neurosurg 70:82–90CrossRef Dörner L, Affke K, Barth H, Mehdorn HM (2009) A subarachnoid haemorrhage primarily presenting as Terson’s syndrome. Cent Eur Neurosurg 70:82–90CrossRef
14.
go back to reference Middleton K, Esselman P, Lim PC (2012) Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil 91:271–274PubMedCrossRef Middleton K, Esselman P, Lim PC (2012) Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil 91:271–274PubMedCrossRef
15.
go back to reference Lee Sang-Hee, Seo Jeong-Hwan, Sung-Hee Park Yu, Won Hui, Ko Myoung-Hwan (2015) Terson syndrome in aneurysmal subarachnoid hemorrhage: a case report. Ann Rehabil Med 39:640–644PubMedPubMedCentralCrossRef Lee Sang-Hee, Seo Jeong-Hwan, Sung-Hee Park Yu, Won Hui, Ko Myoung-Hwan (2015) Terson syndrome in aneurysmal subarachnoid hemorrhage: a case report. Ann Rehabil Med 39:640–644PubMedPubMedCentralCrossRef
16.
go back to reference Evans LP, Newell EA, Mahajan M, Tsang SH, Ferguson PJ, Mahoney J et al (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240–251PubMedPubMedCentralCrossRef Evans LP, Newell EA, Mahajan M, Tsang SH, Ferguson PJ, Mahoney J et al (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240–251PubMedPubMedCentralCrossRef
18.
go back to reference Muslubas IS, Karacorlu M, Hocaoglu M, Ersoz MG, Arf S (2018) Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children. Graefes Arch Clin Exp Ophthalmol 256(3):503–510CrossRef Muslubas IS, Karacorlu M, Hocaoglu M, Ersoz MG, Arf S (2018) Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children. Graefes Arch Clin Exp Ophthalmol 256(3):503–510CrossRef
19.
go back to reference Narayanan R, Taylor SC, Nayaka A, Deshpande R, St Aubin D, Hrisomalos FN et al (2017) Visual outcomes after vitrectomy for Terson syndrome secondary to traumatic brain injury. Ophthalmology 124(1):118–122PubMedCrossRef Narayanan R, Taylor SC, Nayaka A, Deshpande R, St Aubin D, Hrisomalos FN et al (2017) Visual outcomes after vitrectomy for Terson syndrome secondary to traumatic brain injury. Ophthalmology 124(1):118–122PubMedCrossRef
21.
go back to reference Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C (2012) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbaranesthesia and vitreoretinal surgery. Retina 32:1868–1873PubMedCrossRef Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C (2012) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbaranesthesia and vitreoretinal surgery. Retina 32:1868–1873PubMedCrossRef
22.
go back to reference Kobayashi H (2010) Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 36:1115–1119PubMedCrossRef Kobayashi H (2010) Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 36:1115–1119PubMedCrossRef
Metadata
Title
Clinical observations and considerations in the treatment of Terson syndrome using 23G vitrectomy
Authors
Chengqun Ju
Shanshan Li
Chao Huang
Ying Li
Hong kyungwan
Fang Zhou
Jianqiao Li
Publication date
01-09-2020
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 9/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01399-0

Other articles of this Issue 9/2020

International Ophthalmology 9/2020 Go to the issue